The immunohistochemical aspects of protein Mena in cervical lesions

Romanian Journal of Morphology and Embryology

Volumn 50, Issue 2, 2009, Pages 213-216

  Gurzu, Simona ^a   Jung, I ^a   Prantner, I ^b   Chira, L ^a   Ember, I ^b  

^a UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b UNIVERSITY OF PÉCS   (Hungary)

Author keywords

Cervical dysplasia; Cervical squamous carcinoma; Mena immunostain

Indexed keywords

ENA; MAMMALIA;

EID: 70249116757     PISSN: 12200522     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. PULA G., KRAUSE M., Role of Ena/VASP proteins in homeostasis and disease. In: KLUSSMANN E., SCOTT J. (eds), Protein-protein interactions as a new drug targets, Handbook of Experimental Pharmacology 186, Springer- Verlag, Berlin-Heidelberg, 2008, 39-66.
2. GERTLER F. B., NIEBUHR K., REINHARD M., WEHLAND J., SORIANO P., Mena, a relative of VASP and Drosophila Enabled, is implicated in the control of microfilament dynamics, Cell, 1996, 87(2):227-239.
3. WELLS M., OSTOR A. G., CRUM C. P., FRANCESCHI S., TOMMASINO M., NESLAND J. M., GOODMAN A. K., SANKARANARAYANAN R., HANSELAAR A. G., ALBORES-SAAVEDRA J., Tumours of the uterine cervix: Epithelial tumours. In: TAVASSOLI F. A., DEVILEE P. (eds), World Health Organization Classification of Tumours: Pathology and genetics of tumours of the breast and female genital organs, IARC Press, Lyon, 2003, 262-279.
4. DI MODUNGO F., BRONZI G., SCANLAN M. G., DEL BELLO D., CASCIOLI S., VENTURO I., BOTTI C., NICOTRA M. R., MOTTOLESE M., NATALI P. G., SANTONI A., JAGER E., NISTICÒ P., Human Mena protein, a SEREX-defined antigen overexpressed in breast cancer eliciting both humoral and CD8+ T-cell immune response, Int J Cancer, 2004, 109(6):909-918.
5. GURZU S., JUNG I., PRANTNER I., EMBER I., PÁVAI Z., MEZEI T., The expression of cytoskeleton regulatory protein Mena in colorectal lesions, Rom J Morphol Embryol, 2008, 49(3):345-349.
6. +11a isoforms serves as a marker of epithelial phenotype and sensitivity to epidermal growth factor receptor inhibition in human pancreatic cell lines, Clin Cancer Res, 2008, 14(15):4943-4950.
7. HARTMANN L. C., SELLERS T. A., FROST M. H., LINGLE W. L., DEGNIM A. C., GHOSH K., VIERKANT R. A., MALONEY S. D., PANKRATZ V. S., HILLMAN D. W., SUMAN V. J., JOHNSON J., BLAKE C., TLSTY T., VACHON C. M., MELTON L. J. 3RD, VISSCHER D. W., Benign breast disease and the risk of breast cancer, N Engl J Med, 2005, 353(3):229-237.